Financial statements Instytut Badawczo - Rozwojowy Biogened
Balance sheet data of INSTYTUT BADAWCZO - ROZWOJOWY BIOGENED
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|---|---|---|---|---|
Total assets | 5 288 366,06 | 5 303 743,00 | 5 619 814,57 | 6 097 236,60 | 7 646 636,43 |
A. Fixed assets | 58 758,37 | 55 826,85 | 49 395,33 | 43 500,00 | 2 250 426,83 |
B. Current assets | 5 229 607,69 | 5 247 916,15 | 5 570 419,24 | 6 053 736,60 | 5 396 209,60 |
C. Share capital contributions (basic funds) | - | - | - | - | - |
D. Own shares (stocks) | - | - | - | - | - |
Total liabilities | 5 288 366,06 | 5 303 743,00 | 5 619 814,57 | 6 097 236,60 | 7 646 636,43 |
A. Equity | 44 737,19 | 179 521,04 | 1 245 078,82 | 1 639 992,81 | 1 702 928,01 |
B. Liabilities and provisions for liabilities | 5 243 628,87 | 5 124 221,96 | 4 374 735,75 | 4 457 243,79 | 5 943 708,42 |
I. Long-term liabilities | - | - | 0,00 | 0,00 | 0,00 |
II. Short-term liabilities | - | - | 4 374 735,75 | 4 457 243,79 | 4 875 763,30 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.